GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oxford Biomedica OXB.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

484.50p

-5.56%

Close of 20 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Oxford Biomedica — daily OXB

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Oxford Biomedica on TradingView ↗
Market value
£501.3m
Last close × shares
Volume
457.6k
Shares, 20 Nov 2026

About Oxford Biomedica

Its shares trade on LSE under the ticker OXB.L. It has been listed since 15 November 1996. In the fiscal year to 31 December 2025, it reported revenue of £168.7m and a net loss of £30.1m. At that date it held total assets of £325.7m and shareholders' equity of £91.3m.

Oxford Biomedica Plc is a biopharmaceutical company, which engages in the research and development of gene and cell therapy. The company is headquartered in Oxford, Oxfordshire. The firm and its subsidiaries has developed lentiviral vector delivery platform (LentiVector), which the Company leverages to develop in vivo and ex vivo products both in-house and with partners. Its LentiVector delivery platform has created a portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology, liver and central nervous system (CNS) disorders. The firm's product pipeline includes OXB-302, OXB-203, OXB-204 and OXB-103 and OXB-401 and addresses neurodegenerative and a range of cancers. The firm has also developed partnership with various pharmaceutical companies to develop potential gene and cell therapy products. Its partnered products include AXO-LENTI-PD, SAR 422459 and SAR421869.

Figures and description from our data supplier, not checked against the company's own report.

More about Oxford Biomedica →

Latest on Oxford Biomedica

Our reporting

Next results

15 Apr 2027

Due on 15 Apr 2027. Analysts expect earnings of -0.02 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Oxford Biomedica's ticker?

Oxford Biomedica trades as OXB.L on LSE, under ISIN GB00BDFBVT43.

What was Oxford Biomedica's last closing price?

484.50p on 20 Nov 2026. The figure is in GBp and is never converted.

When does Oxford Biomedica next report results?

Results are expected on 15 Apr 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.